Gene-based, personalized dosing.
Answers to common questions about the evidence, precision and dosing of fully personalized micronutrient supply.
Scientific substantiation of gene-based dosing
For the finished, fully personalized combination product there are no large randomized studies proving an outcome benefit over standardized supplementation. That is true for personalized nutrigenetics as a whole — and we don't claim otherwise.
What is substantiated is the level beneath it: the individual gene-nutrient interactions on which the adaptation is based — each graded by confidence. Well-documented, repeatedly replicated examples, each with a peer-reviewed review:
The best-studied interaction of them all
More than 300 studies, including 11 placebo-controlled intervention trials.
Read the review → HFE — IronA clear, replicated interaction
Increased iron storage — a restriction makes sense.
Read the review → VDR — Vitamin D3Action at the receptor
Receptor activity and the personalized dose derived from it.
Read the review → NQO1 — Coenzyme Q10About one person in eleven
… can barely activate Q10 — with a direct consequence for dosing.
Read the review →Part of the interpretation is — as everywhere in medicine — an expert recommendation. For a slightly deficient vitamin D level, five different doctors would probably recommend five different dosages, and all five are legitimate. Precision here does not mean the one true number, but a professionally grounded, transparent interpretation within a sensible corridor.
How the dosage is derived
- Base recommendation per nutrient
by sex and age — not a lifelong fixed value, but one that changes from year to year.
- Factors are added or subtracted
Higher body weight means more energy conversion and a higher consumption of the energy nutrients; competitive sport raises the requirement; and all of it shifts with age.
- Genetic strengths and weaknesses
are analyzed and, where a weakness is present, weighted using studies or in-house scores: maximum genetic risk leads to the maximum active-ingredient dose, a below-average genetic problem to a below-average dose.
- Blood values take precedence
where available: a deficiency always leads to the maximum dose of the nutrient, an excess always to its exclusion — independent of the genetics.
- Safety ceiling
Even with a particularly healthy diet plus supplementation, we stay below the EFSA Upper Safe Limits (Tolerable Upper Intake Level). In some cases additional statutory maximum amounts for food supplements apply, which we comply with — even where studies would suggest a higher dosage.
Robustness of the precision claims
- Over 700 quintillion possible outcomes arise purely from combinatorics: we analyze more than 50 genes, each with 3 possible states (genotypes). This yields 700 quintillion different potential genetic profiles — the number of theoretically possible starting constellations that the system responds to.
- Down to the microgram: every single nutrient is dosed to the microgram for the individual person, and each person can receive different microgram values. There is no coarse grid (not either 1 g of vitamin C or none at all), but a fine, algorithmically calculated gradation per active ingredient and person.
Dosing in the lower range
The system deliberately also regulates requirements downward. The charge of subtherapeutic dosing does not hold up professionally, because a different frame of reference applies:
- Meeting requirements rather than pharmacotherapy: "Subtherapeutic" is a pharmaceutical term — the active ingredient would have to reach a therapeutic threshold. The reference here is the physiological requirement, not a therapeutic threshold.
- Turning it down is a feature: a lower dose is professionally correct when genotype or blood value point to a lower requirement — and in order to avoid over-supply. For many micronutrients, more is not better, but U-shaped in its risk (iron, vitamin A, selenium, zinc/copper balance, folic-acid masking).
- Effective means meeting the individual requirement, not hitting a fixed high dose. The doses remain within evidence-based nutritional ranges — adjusted up and down, but not at trace level.
- Delimitation: genuine deficiency or disease states belong in medical hands (the medical track). The lifestyle product optimizes intake within the healthy range.
Kind regards
Dr. Daniel Wallerstorfer
Chief Executive Officer, Novogenia GmbH
This article serves to provide scientific background and does not constitute medical advice, diagnosis or treatment recommendation. Personalized supplements optimize intake within the healthy range; genuine deficiency or disease states belong in medical hands.
